Back to school: Shire trains at NIBRT ahead of biologics site opening

By Flora Southey contact

- Last updated on GMT

GettyImages/Romanovskyy
GettyImages/Romanovskyy
Shire is sending its employees to the National Institute for Bioprocessing and Research Training prior to opening its biomanufacturing site in Dunboyne, Ireland.

Under the professional training and development collaboration, Shire will employ the NIBRT-GE Single Use Technology Centre of Excellence​ and Emerson manufacturing automation platform​ to cover all aspects of biopharma manufacturing.

While all Dunboyne-based employees will receive training, the National Institute for Bioprocessing and Research Training (NIBRT) will train 20 staff members on-site for a period of 12 months.

NIBRT spokesperson Alison Quinn told us employees – who will receive training for the duration of the commissioning, validation, and start-up of the Dunboyne site – will develop quality processes while at the institute. 

“Training will cover all aspects of the biopharma manufacturing process, with a focus on cell culture, downstream processing, and bioanalytics,” ​she told us.

Shire’s employees will begin training in Q3, 2018.

Single-use at Dunboyne

Shire announced plans​ to construct the $400m biologics manufacturing facility in April, 2016.

A spokesperson told us the 120-acre campus will “adopt single use technology in the manufacturing processes, will be a highly automated facility and will also be the European Quality Control Hub for Shire’s biologics portfolio.”

The expansion – which will create approximately 400 jobs – responds to an increase in product demand, she added.

Related news

Show more

Related products

show more

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Custom manufacturing of protease inhibitor PMSF

Custom manufacturing of protease inhibitor PMSF

Actylis – The Partner of Choice | 09-Nov-2022 | Technical / White Paper

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...

Related suppliers

Follow us

Products

View more

Webinars